For: | Jakstaite A, Maziukiene A, Silkuniene G, Kmieliute K, Gulbinas A, Dambrauskas Z. HuR mediated post-transcriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancer. World J Gastroenterol 2015; 21(46): 13004-13019 [PMID: 26675757 DOI: 10.3748/wjg.v21.i46.13004] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i46/13004.htm |
Number | Citing Articles |
1 |
Atousa Ghorbani, Fatemeh Hosseinie, Saeideh Khorshid Sokhangouy, Muhammad Islampanah, Fatemeh khojasteh-Leylakoohi, Mina Maftooh, Mohammadreza Nassiri, Seyed Mahdi Hassanian, Majid Ghayour-Mobarhan, Gordon A Ferns, Majid Khazaei, Elham Nazari, Amir Avan. The prognostic, diagnostic, and therapeutic impact of Long noncoding RNAs in gastric cancer. Cancer Genetics 2024; : 14 doi: 10.1016/j.cancergen.2023.12.006
|
2 |
Zigui Zou, Tianshi Ma, Xuezhi He, Jinxing Zhou, Hongwei Ma, Min Xie, Yanhua Liu, Die Lu, Shihao Di, Zhihong Zhang. Long intergenic non-coding RNA 00324 promotes gastric cancer cell proliferation via binding with HuR and stabilizing FAM83B expression. Cell Death & Disease 2018; 9(7) doi: 10.1038/s41419-018-0758-8
|
3 |
Takashi Kasukabe, Yoshio Honma, Junko Okabe-Kado, Yusuke Higuchi, Nobuo Kato, Shunichi Kumakura. Combined treatment with cotylenin A and phenethyl isothiocyanate induces strong antitumor activity mainly through the induction of ferroptotic cell death in human pancreatic cancer cells. Oncology Reports 2016; 36(2): 968 doi: 10.3892/or.2016.4867
|
4 |
Vittoria Borgonetti, Elisabetta Coppi, Nicoletta Galeotti. Targeting the RNA-Binding Protein HuR as Potential Thera-Peutic Approach for Neurological Disorders: Focus on Amyo-Trophic Lateral Sclerosis (ALS), Spinal Muscle Atrophy (SMA) and Multiple Sclerosis. International Journal of Molecular Sciences 2021; 22(19): 10394 doi: 10.3390/ijms221910394
|
5 |
Min Jin, Jingjing Wu, Linli Shi, Bin Zhou, Fumei Shang, Xiaona Chang, Xiaochuan Dong, Shenghe Deng, Li Liu, Kailin Cai, Xiu Nie, Tao Zhang, Jun Fan, Hongli Liu. Gut microbiota distinct between colorectal cancers with deficient and proficient mismatch repair: A study of 230 CRC patients. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.993285
|
6 |
Amirreza Bitaraf, Ehsan Razmara, Babak Bakhshinejad, Hassan Yousefi, Mousa Vatanmakanian, Masoud Garshasbi, William C. Cho, Sadegh Babashah. The oncogenic and tumor suppressive roles of RNA‐binding proteins in human cancers. Journal of Cellular Physiology 2021; 236(9): 6200 doi: 10.1002/jcp.30311
|
7 |
Yeon Soo Kim, Priscilla W. Tang, Jaclyn E. Welles, Weihua Pan, Zaineb Javed, Amal Taher Elhaw, Karthikeyan Mythreye, Scot R. Kimball, Nadine Hempel. HuR-dependent SOD2 protein synthesis is an early adaptation to anchorage-independence. Redox Biology 2022; 53: 102329 doi: 10.1016/j.redox.2022.102329
|
8 |
Huamei Wei, Xianjian Wu, Lizheng Huang, Chen Long, Qi Lu, Zheng Huang, Yanyan Huang, Wenchuan Li, Jian Pu. LncRNA MEG3 Reduces the Ratio of M2/M1 Macrophages Through the HuR/CCL5 Axis in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2024; : 543 doi: 10.2147/JHC.S449090
|
9 |
Xiaoqing Song, Xin Shi, Wenjuan Li, Fa Zhang, Zhonglin Cai. The RNA-Binding Protein HuR in Digestive System Tumors. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/9656051
|
10 |
Kenneth J. Dery, Kojiro Nakamura, Kentaro Kadono, Hirofumi Hirao, Shoichi Kageyama, Takahiro Ito, Hidenobu Kojima, Fady M. Kaldas, Ronald W. Busuttil, Jerzy W. Kupiec‐Weglinski. Human Antigen R (HuR): A Regulator of Heme Oxygenase‐1 Cytoprotection in Mouse and Human Liver Transplant Injury. Hepatology 2020; 72(3): 1056 doi: 10.1002/hep.31093
|
11 |
Wei Chai, Ruhai Liu, Fengshan Li, Zhiquan Zhang, Bao Lei. Long noncoding RNA TSLNC8 enhances pancreatic cancer aggressiveness by regulating CTNNB1 expression via association with HuR. Human Cell 2021; 34(1): 165 doi: 10.1007/s13577-020-00429-4
|
12 |
Eviania Likos, Asmita Bhattarai, Crystal M. Weyman, Girish C. Shukla. The androgen receptor messenger RNA: what do we know?. RNA Biology 2022; 19(1): 819 doi: 10.1080/15476286.2022.2084839
|
13 |
Wei Song, Yimin Sun, Jie Lin, Xiaoqin Bi. Current research on head and neck cancer-associated long noncoding RNAs. Oncotarget 2018; 9(1): 1403 doi: 10.18632/oncotarget.22608
|
14 |
Liang Han, Jie Jiang, Qingyong Ma, Zheng Wu, Zheng Wang. The inhibition of heme oxygenase-1 enhances the chemosensitivity and suppresses the proliferation of pancreatic cancer cells through the SHH signaling pathway. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4363
|
15 |
Rajeswari Raguraman, Santny Shanmugarama, Meghna Mehta, Jo Elle Peterson, Yan D. Zhao, Anupama Munshi, Rajagopal Ramesh. Drug delivery approaches for HuR-targeted therapy for lung cancer. Advanced Drug Delivery Reviews 2022; 180: 114068 doi: 10.1016/j.addr.2021.114068
|
16 |
Mingxia Wu, Christy W.S. Tong, Wei Yan, Kenneth K.W. To, William C.S. Cho. The RNA Binding Protein HuR: a Promising Drug Target for Anticancer Therapy. Current Cancer Drug Targets 2019; 19(5): 382 doi: 10.2174/1568009618666181031145953
|
17 |
Limei Hu, Rui Ding, Xiangping Nie. Comparison of toxic effects of atorvastatin and gemfibrozil on Daphnia magna. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 2022; 252: 109224 doi: 10.1016/j.cbpc.2021.109224
|
18 |
Ausra Lukosiute-Urboniene, Aldona Jasukaitiene, Giedre Silkuniene, Vidmantas Barauskas, Antanas Gulbinas, Zilvinas Dambrauskas. Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer. World Journal of Gastroenterology 2019; 25(2): 205-219 doi: 10.3748/wjg.v25.i2.205
|
19 |
Wei Xu, Chao Chen, Ruijun Xu, Yifan Li, Ruixi Hu, Zhikun Li, Xiaodong Zhu. Knockdown of HuR represses osteosarcoma cells migration, invasion and stemness through inhibition of YAP activation and increases susceptibility to chemotherapeutic agents. Biomedicine & Pharmacotherapy 2018; 102: 587 doi: 10.1016/j.biopha.2018.03.098
|
20 |
Fenghai Zhou, Fa Zhang, Chuan Zhou, Mengtian Liang, Zhonglin Cai, Haidi Lv, Wenjuan Li, Xupan Wei. Human antigen R and drug resistance in tumors. Investigational New Drugs 2019; 37(5): 1107 doi: 10.1007/s10637-018-00723-x
|
21 |
Hao Wang, Nannan Ding, Jian Guo, Jiazeng Xia, Yulan Ruan. Dysregulation of TTP and HuR plays an important role in cancers. Tumor Biology 2016; 37(11): 14451 doi: 10.1007/s13277-016-5397-z
|
22 |
Darius Stukas, Aldona Jasukaitiene, Arenida Bartkeviciene, Jason Matthews, Toivo Maimets, Indrek Teino, Kristaps Jaudzems, Antanas Gulbinas, Zilvinas Dambrauskas. Targeting AHR Increases Pancreatic Cancer Cell Sensitivity to Gemcitabine through the ELAVL1-DCK Pathway. International Journal of Molecular Sciences 2023; 24(17): 13155 doi: 10.3390/ijms241713155
|
23 |
Kazuhiro Toyota, Yoshiaki Murakami, Naru Kondo, Kenichiro Uemura, Naoya Nakagawa, Shinya Takahashi, Taijiro Sueda. Cytoplasmic Hu-Antigen R (HuR) Expression is Associated with Poor Survival in Patients with Surgically Resected Cholangiocarcinoma Treated with Adjuvant Gemcitabine-Based Chemotherapy. Annals of Surgical Oncology 2018; 25(5): 1202 doi: 10.1245/s10434-018-6392-y
|
24 |
Jeong-Ran Lee. Study of the Applicability of Toegye’s Thoughts to Character Education in Sports: Focused on Ten Diagrams on Sage Learning. Journal of Korean Association of Physical Education and Sport for Girls and Women 2020; 34(2): 89 doi: 10.16915/jkapesgw.2020.6.34.2.89
|
25 |
Yuki Yamaguchi, Takashi Kasukabe, Shunichi Kumakura. Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4259
|
26 |
Meifen Chu, Tongtong Wang, Aihua Sun, Yu Chen. Nimesulide inhibits proliferation and induces apoptosis of pancreatic cancer cells by enhancing expression of PTEN. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6191
|
27 |
Asma Vafadar, Zahra Shabaninejad, Ahmad Movahedpour, Soheila Mohammadi, Sima Fathullahzadeh, Hamid R. Mirzaei, Afshin Namdar, Amir Savardashtaki, Hamed Mirzaei. Long Non-Coding RNAs As Epigenetic Regulators in Cancer. Current Pharmaceutical Design 2019; 25(33): 3563 doi: 10.2174/1381612825666190830161528
|
28 |
Noriko Okuni, Yoshio Honma, Takeshi Urano, Kenji Tamura. Romidepsin and tamoxifen cooperatively induce senescence of pancreatic cancer cells through downregulation of FOXM1 expression and induction of reactive oxygen species/lipid peroxidation. Molecular Biology Reports 2022; 49(5): 3519 doi: 10.1007/s11033-022-07192-9
|